Skip to main content
$7.24 $0.31 (4.5%)

04:00 PM EST on 01/21/22

Bluebird Bio Inc. (NASDAQ:BLUE)

CAPS Rating: 4 out of 5

Current Price $7.24 Mkt Cap $507.6M
Open $6.79 P/E Ratio 0.00
Prev. Close $7.24 Div. (Yield) $0.00 (0.0%)
Daily Range $6.75 - $7.39 Volume 11,802,723
52-Wk Range $6.75 - $48.92 Avg. Daily Vol. 2,537,411

Caps

How do you think NASDAQ:BLUE will perform against the market?

Add Stock to CAPS Watchlist

All Players

234 Outperform
17 Underperform
 

All-Star Players

62 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BLUE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Car12703 (< 20)
Submitted December 20, 2021

From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.

TMFacarchidi (< 20)
Submitted December 01, 2021

Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.

NASDAQ:BLUE VS S&P 500 (SPY)

Fools bullish on NASDAQ:BLUE are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about BLUE.

Recs

1
Member Avatar Car12703 (< 20) Submitted: 12/20/2021 10:25:57 AM : Outperform Start Price: $8.32 NASDAQ:BLUE Score: -9.06

From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2

Re-establishing this position at a lower price.

Recs

1
Member Avatar Ficktory (20.75) Submitted: 12/13/2021 2:27:25 PM : Outperform Start Price: $9.36 NASDAQ:BLUE Score: -15.80

Gene therapies will be a huge growth sector in health care in the next decade.

Recs

1
Member Avatar TMFacarchidi (< 20) Submitted: 12/1/2021 10:19:45 AM : Underperform Start Price: $10.58 NASDAQ:BLUE Score: +25.85

Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.

Leaderboard

Find the members with the highest scoring picks in BLUE.

Score Leader

DoubleBagel

DoubleBagel (35.07) Score: +669.10

The Score Leader is the player with the highest score across all their picks in BLUE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
secohen11 31.59 7/2/2013 Underperform 1Y $26.20 -72.06% +172.91% +244.97 0 Comment
saab93boi < 20 6/19/2013 Underperform 5Y $25.68 -71.49% +167.45% +238.94 0 Comment
rwpaules 79.60 6/19/2013 Underperform 3Y $25.09 -70.83% +165.72% +236.54 0 Comment
biotechf 79.81 1/22/2016 Underperform 3M $44.44 -83.53% +132.26% +215.78 0 Comment
MotleyFolJohn < 20 2/2/2015 Underperform 1Y $93.98 -92.21% +120.21% +212.42 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CommodityBuyer < 20 7/10/2015 Underperform 5Y $160.69 -95.44% +112.02% +207.46 0 Comment
pro64grammer 28.67 12/9/2014 Underperform 5Y $79.58 -90.80% +114.82% +205.62 0 Comment
3rdChanceTom 87.96 3/11/2016 Underperform 5Y $45.77 -84.01% +118.48% +202.49 0 Comment
GreenAB 28.10 3/5/2015 Underperform NS $106.20 -93.11% +108.65% +201.75 0 Comment
coptermech66 < 20 10/29/2015 Underperform 3Y $79.54 -90.80% +110.58% +201.38 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BLUE.